Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study
ME Stein, Z Bernstein, M Tsalic, K Drumea… - American journal of …, 2002 - journals.lww.com
The objective of this study was to investigate the efficacy of our treatment regimen in
metastatic melanoma. Thirty patients entered the study after undergoing a thorough …
metastatic melanoma. Thirty patients entered the study after undergoing a thorough …
Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study.
ME Stein, Z Bernstein, M Tsalic, K Drumea… - American Journal of …, 2002 - europepmc.org
The objective of this study was to investigate the efficacy of our treatment regimen in
metastatic melanoma. Thirty patients entered the study after undergoing a thorough …
metastatic melanoma. Thirty patients entered the study after undergoing a thorough …
[引用][C] Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: A prospective phase II study
ME STEIN, Z BERNSTEIN, M TSALIC… - American journal of …, 2002 - pascal-francis.inist.fr
Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon
for metastatic melanoma: A prospective phase II study CNRS Inist Pascal-Francis CNRS Pascal …
for metastatic melanoma: A prospective phase II study CNRS Inist Pascal-Francis CNRS Pascal …
Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study
ME Stein, Z Bernstein, M Tsalic… - … journal of clinical …, 2002 - pubmed.ncbi.nlm.nih.gov
The objective of this study was to investigate the efficacy of our treatment regimen in
metastatic melanoma. Thirty patients entered the study after undergoing a thorough …
metastatic melanoma. Thirty patients entered the study after undergoing a thorough …